AlphaCentric Advisors »

Disc Medicine shares owned by AlphaCentric Advisors

Quarter-by-quarter ownership of Disc Medicine (IRON) shares owned by AlphaCentric Advisors from 13F filings

Historical chart of AlphaCentric Advisors investment in Disc Medicine

Tip: Access up to 7 years of quarterly data

All positions including Disc Medicine held by AlphaCentric Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Disc Medicine by AlphaCentric Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $298k 3.8k 79.41

More positions owned by AlphaCentric Advisors

Gilead Sciences (GILD)
Invitation Homes (INVH)
Ishares Tr Mbs Etf (MBB)
Euronet Worldwide (EEFT)
Vertex Pharmaceuticals Incorporated (VRTX)
Astrazeneca Sponsored Adr
Alpine Income Ppty Tr (PINE)
Invesco Exchange Traded Fd T S&p500 Pur Val (RPV)
Ishares Tr Rus 1000 Val Etf (IWD)
Ionis Pharmaceuticals (IONS)
Stereotaxis Com New (STXS)
Incyte Corporation (INCY)
Insmed Com Par $.01 (INSM)
AMREP Corporation (AXR)
Argenx Se Sponsored Adr (ARGX)

View all positions for AlphaCentric Advisors

Top funds holding Disc Medicine

FMR
BlackRock
Vanguard Group
RA Capital Management
Atlas Venture Life Science Advisors
OrbiMed Advisors
Wellington Management Company
Frazier Life Sciences Management
State Street Corporation
Siren
Woodline Partners
Goldman Sachs Group
Jpmorgan Chase & Co
Vestal Point Capital
Geode Capital Management

View all funds holding Disc Medicine